Monthly penicillin to prevent syphilis during pregnancy
Official title: Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil
Run by University of California, Los Angeles · NCT07189208 · Data updated 2026-11-12
This trial will test whether monthly benzathine penicillin injections plus counseling in the third trimester can prevent syphilis in pregnant people at higher risk.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 500 (estimated) |
| Sponsor | University of California, Los Angeles Academic / other |
| Locations | 4 sites (Duque de Caxias, Rio de Janeiro and 3 other locations) |
| Status | Recruiting |
| Started | September 24, 2025 |
| Main results expected | December 1, 2029 |
| Study ends | July 31, 2030 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT07189208 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant people with a viable pregnancy who are negative for syphilis at baseline, meet one or more elevated-risk criteria (for example recent STI history, HIV infection, age under 21, recent new partners, late prenatal care, or residence in a high-prevalence area), can consent, and can attend monthly prenatal visits at a participating site are ideal candidates.
✕Probably not a fit
People with a positive baseline syphilis test, a penicillin allergy, non-viable or very high-risk pregnancies, lack of sexual activity during the study period, or contraindications to IM injections would not be expected to benefit from this prophylaxis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, unblinded Phase 2 trial comparing monthly intramuscular benzathine penicillin G (2.4 million units) plus enhanced counseling and testing to enhanced standard of care (counseling and monthly treponemal and non-treponemal tests) beginning at 28 weeks of pregnancy. Participants who are negative for syphilis at baseline and meet prespecified risk criteria will receive monthly clinic visits for testing and injections through delivery. The primary maternal endpoint is absence of treponemal and non-treponemal evidence of syphilis at delivery, and the primary infant endpoint is absence of congenital syphilis. Safety monitoring will record adverse reactions to penicillin and any pregnancy-related complications.
Why it matters
Potential benefit: If successful, this approach could lower maternal syphilis rates and reduce cases of congenital syphilis and related infant illness.
How similar studies have gone: Using routine monthly benzathine penicillin as prophylaxis in pregnancy is a relatively novel approach with limited prior trial data and has not been widely tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Uncomplicated, viable pregnancy 2. Elevated risk for syphilis acquisition (one or more of the following): 1. Prior history of STIs last 3 years 2. HIV infection 3. Age \< 21 years 4. In a sexual partnership of \< 3 mo., or \> 3 sexual partners in the last 6 mo. 5. Late initiation of prenatal care (\> 14 weeks of pregnancy) 6. Residence in area where syphilis prevalence is 10% or higher. 3. Ability to provide written informed consent 4. No allergy to penicillin 5. Prenatal care at one of the sites participating in the study 6. Ongoing sexual activity during study period. 7. Negative rapid treponemal test at baseline. Exclusion Criteria: 1. Non-viable pregnancy 2. Very high risk pregnancy 3. Inability to provide written informed consent 4. Allergy to penicillin 5. Positive rapid treponemal test at baseline 6. Lack of sexual activity during study period. 7. Any persisting coagulation disorder that would contraindicate IM injections.
Where it's running
-
Policlínica Hospital Municipal Duque de Caxias
Duque de Caxias, Rio de Janeiro, Brazil Recruiting -
Hospital Federal dos Servidores do Estado
Rio de Janeiro, Rio de Janeiro, Brazil Recruiting -
Centro de Referencia e Atenção Especializada a Saúde da Mulher (CRAESM)
Duque de Caxias, Rio de Janeiro, Brazil Not yet recruiting -
Unidade Básica de Saúde José de Freitas
Duque de Caxias, Rio de Janeiro, Brazil Not yet recruiting
Study contacts
- Study coordinator: Karin Nielsen, MD
- Email: knielsen@mednet.ucla.edu
- Phone: 310-825-5235
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CGM-guided carb awareness education for adults with Type 1 diabetes
This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.
-
Protein supplements with or without spices to protect muscle for people on GLP-1 weight loss meds
This pilot test checks whether daily whey protein, with or without mixed spices, helps preserve muscle mass and strength in adults using GLP-1 weight-loss medicines.
-
Diet Quality Matters: A Nutrition Education Program for Los Angeles Food Rx Participants
A community-based program will test whether tailored nutrition education and cooking sessions can help low-income adults in LA improve diet quality and reduce cardiometabolic risk.
-
Diet quality in older adults and how two dietary tools compare
This study tests two diet-quality questionnaires in adults 60 and older who use LA Food Rx produce programs to see which better reflects their eating and BMI.
-
Neuroplastic pain education and guided breathing during awake cataract surgery
This trial tests whether the STEIN Protocol, a non-drug approach with pain education, guided imagery, and paced breathing, helps adults having cataract surgery require less pain medicine and feel less anxious.
-
Care Disengagement Prevention for People Living with HIV in Indonesia
This intervention tests a stigma-reduction approach to help people living with HIV in Indonesia stay connected with HIV care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.